DISHMAN

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Ms. Shrima G. Dave, Asst. company Secretary and compliance officer of the company, is appointed as a "Company Secretary and Compliance officer" of the Company w.e.f August 24, 2016.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Ms. Shrima G. Dave, Asst. Company Secretary of the Company is designated as Compliance Officer of the Company w.e.f. May 21, 2016 in place of Ms. Pinaz H. Pithadia.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr Tushar D Shah has resigned from the post of Company Secretary & Compliance Officer of the Company and his resignation has been accepted with effect from the close of normal office hours on February 25, 2016.Ms. Pinaz H Pithadia, Asst. Company Secretary of the Company is designated as Compliance Officer of the Company w.e.f. February 26, 2016.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of Directors vide circular resolution dated April 2, 2015, have approved the appointment of Mr. Rajendra S. Shah as an Additional Director of the Company, Mr. Rajendra S. Shah shall hold office as an Additional Director w.e.f. April 2, 2015 till the ensuing Annual General Meeting of the Company. The Board has considered him as an Independent Director in terms of the provisions of the Companies Act, 2013 and Listing Agreement.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding appointment of Mr. S. K. Das as Independent Director on the Board of the Company and Resignation of Mr. Y.B.Desai as an Independent Director of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Rajashekhar Bhat has been appointed as a Global Chief Financial Officer ("CFO") of the Dishman Group of Companies w.e.f. April 01, 2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Tushar Shah has been appointed as a "Company Secretary and Compliance officer" of the Company w.e.f March 27, 2014.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Deepak S. Pandya Vice President (Legal) & Company Secretary has resigned from the services of the Company. The Company accepted his resignation and relieved him of his responsibilities effective close of business hours on December 29, 2013. Consequent to his resignation as Company Secretary, Mr. Pandya also ceases to be Compliance Officer of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Mark Griffiths, who is CEO of Carbogen Amcis AG., Switzerland, has been appointed as CEO of Dishman Group of Companies, world wide.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that Mr. Mark Griffiths, who is CEO of Carbogen Amcis AG., Switzerland, has been appointed as CEO of Dishman Group of Companies, world wide.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange vide its letter dated June 01, 2009, that: "The Board of Directors of the Company has taken today, the following decisions: 1) Mr. Janmejay R. Vyas, Managing Director of the Company is appointed as Chairman of the Company and his designation has been changed to Chairman & Managing Director w.e.f. 1st June, 2009. 2) Mr. Arpit J. Vyas is appointed as an Additional Director of the Company w.e.f. 1st June, 2009. He has also been appointed as Whole-time Director of the Company for a period of five years w.e.f. 1st June, 2009 su

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that "Mr. Divyabhash C. Anjaria ceased to be a Director of Dishman Pharmaceuticals and Chemicals Ltd. ("Company") upon resignation with effect from 9th February, 2007 and his resignation has been accepted by the Board of the Company. Consequent to this, Mr. Divyabhash C. Anjaria also ceased to be a member of Audit Committee and Remuneration Committee of the Company."

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that at the Board of Directors of the Company at their meeting held on May 23, 2006, the following decisions were taken by the BoDs of the Company : (a) Resolution in respect of the Re-appointment of Mrs. Deohooti J. Vyas as Wholetime Director of the Company for a further period of 5 (five) years w.e.f. September 03, 2006 and increase in remuneration payable to her has been passed, subject to approval of the Members in ensuing Annual General Meeting to be held on June 29, 2006. The present term of appointment of Mrs. Deoh

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that at the meeting of BODs of the company held on January 28, 2005, the resignation of Mr. Henk Pluim, has been accepted and he is ceased to be a Director of the company w.e.f January 28,2005.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that at the meeting of the BOD of the company held on October 28, 2004, Mr. D C Anjaria was appointed as an Additional Director of the Company with immediate effect.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that the Company has made an application on October 21, 2004 [in prescribed form 25-A of the Companies (Central Government's) general rules and forms, 1956] for the re-appointment of a Managing Director of the company for a further period of 5 years whose existing tenure expires on 28/02/2005. The application is also meant for payment of renumeration to him. The whole procedure as per the provisions of the Companies Act, was followed for making this application.